Literature DB >> 14005930

Pseudouridine metabolism. II. Urinary excretion in gout, psoriasis, leukemia, and heterozygous oroticaciduria.

S WEISSMAN, A Z EISEN, M KARON.   

Abstract

Entities:  

Keywords:  GOUT/urine; NUCLEOSIDES AND NUCLEOTIDES/urine; OROTIC ACID/urine; PSORIASIS/urine

Mesh:

Substances:

Year:  1962        PMID: 14005930

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  6 in total

1.  THE EFFECT OF 6-AZAURIDINE ADMINISTRATION ON DE NOVO PYRIMIDINE PRODUCTION IN CHRONIC MYELOGENOUS LEUKEMIA.

Authors:  V H BONO; S M WEISSMAN; E FREI
Journal:  J Clin Invest       Date:  1964-07       Impact factor: 14.808

2.  Clinical and biochemical studies of Paget's disease of bone with emphasis on the effects of RNA inhibitors actinomycin D and mithrawycin.

Authors:  J J Fennelly
Journal:  Ir J Med Sci       Date:  1971-10       Impact factor: 1.568

Review 3.  A current review of psoriasis.

Authors:  E M Farber; R P McClintock
Journal:  Calif Med       Date:  1968-06

4.  Pseudouridine excretion--a reflection of high RNA turnover in Paget's disease.

Authors:  J J Fennelly; A Hogan
Journal:  Ir J Med Sci       Date:  1972 Jul-Sep       Impact factor: 1.568

5.  The excretion of urinary pseudouridine in patients treated with allopurinol and oxipurinol.

Authors:  H A Simmonds
Journal:  Biochem J       Date:  1969-02       Impact factor: 3.857

6.  Purine and pyrimidine excretion in psoriasis: a comparison with healthy controls during allopurinol therapy.

Authors:  H A Simmonds; A Bowyer
Journal:  Br J Clin Pharmacol       Date:  1974-04       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.